NAMS Overview Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker | NAMSU.S.: Nasdaq +Watchlist You must be logged in to create alerts After Hours Last Updated:Apr 15, 2025 4:34 p.m.EDTDelayed quote $16.06 0.000.00% After Hours Volume:13.68K ...
NAMS Overview Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker | NAMSU.S.: Nasdaq +Watchlist You must be logged in to create alerts After Hours Last Updated:Apr 14, 2025 4:05 p.m.EDTDelayed quote $16.42 0.000.00% After Hours Volume:13.11K ...
H.C. Wainwright initiated coverage of NewAmsterdam Pharma (NAMS) with a Buy rating and $48 price target. The firm believes obicetrapib, as a low-dose, oral, once-daily treatment, may emerge as the preferred lipid-lowering therapy for patients with hypercholesterolemia, as monotherapy or as ...
NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, ...
(with or without a progestin)is the most effective treatment of VMS and VVA due to menopause according to NAMS.According to Symphony Health Solutions,total U.S.sales of FDA-approved oral,transdermal,and suppository estrogen(with and without a 109、 progestin)hormone therapy products were ...
NAMS | Complete NewAmsterdam Pharma Co. N.V. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
NAMS Overview Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker | NAMSU.S.: Nasdaq +Watchlist You must be logged in to create alerts After Hours Last Updated:Apr 17, 2025 6:10 p.m.EDTDelayed quote $16.49 0.150.92% After Hours Volume:12.82K ...
Seagate Technology Holdings is Now Oversold (STX) BNK Invest • 11 minutes ago Xenon Pharmaceuticals Enters Oversold Territory (XENE) BNK Invest • 11 minutes ago NewAmsterdam Pharma is Now Oversold (NAMS) BNK Invest • 11 minutes ago See All News Trending Mutual FundsReturns...
Septerna is advancing an oral small molecule thyroid stimulating hormone receptor (TSHR) NAM program designed to be a disease-modifying treatment for Graves’ disease and thyroid eye disease (TED). In a novel mouse model of Graves’ disease, the TSHR NAMs have demonstrated the abilit...
Stay up-to-date on IBX Group Inc (IBXG) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.